TATVA CHIN PHARM CHEM LTD (TATVA)

NSE: ₹1,191.10
BSE: ₹1,190.75
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 114.36 96.67 84.21 98.27 105.46 83.49 85.90 107.86 116.86 123.52 131.33 134.14
YOY Revenue Growth % 29.37% 7.3% -30.18% -21.08% -7.78% -13.63% 2.01% 9.77% 10.81% 47.94% 52.9% 24.36%
Other Income 1.02 0.76 1.21 4.53 1.17 0.38 0.04 0.72 1.16 1.01 1.73 -0.35
Total Income 115.38 97.43 85.42 102.79 106.64 83.87 85.94 108.59 118.02 124.52 133.07 133.80
Total Expenses + 101.96 86.21 80.17 89.10 99.83 84.89 86.18 106.56 108.92 110.86 115.41 117.21
Cost of Materials Consumed 47.22 46.37 41.76 43.41 41.52 39.29 45.04 47.92 63.89 61.99 69.61 67.26
Employee Benefit Expense 11.56 14.07 14.77 14.37 12.70 12.94 13.23 14.05 14.09 14.95 16.82 17.07
Other Expenses 23.41 25.04 21.10 26.81 23.16 22.24 24.07 27.18 27.10 31.49 33.88 32.76
Operating Profit 12.41 10.46 4.03 9.16 5.64 -1.40 -0.28 1.31 7.95 12.66 15.92 16.94
OPM % 10.8% 10.8% 4.8% 9.3% 5.3% -1.7% -0.3% 1.2% 6.8% 10.2% 12.1% 12.6%
Profit Before Tax + 13.42 11.21 5.24 13.69 6.81 -1.02 -0.24 2.03 9.10 13.66 17.66 16.59
Tax Expense 3.92 3.43 1.79 4.08 1.60 -0.36 -0.37 1.00 2.45 3.75 2.49 6.27
Tax % 29.2% 30.6% 34.1% 29.8% 23.5% - - 49.2% 26.9% 27.4% 14.1% 37.8%
Profit After Tax 9.50 7.78 3.46 9.61 5.21 -0.66 0.14 1.03 6.65 9.92 15.17 10.32
EPS (Basic) 4.29 3.43 1.48 4.11 2.23 -0.29 0.06 0.44 2.84 4.24 6.49 4.41

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022
Revenue from Operations 505.86 382.71 393.50 423.61 433.65
YOY Revenue Growth % 32.18% -2.74% -7.11% -2.31% -
Other Income 3.55 2.32 7.51 5.74 8.89
Total Income 509.41 385.03 401.01 429.36 442.54
Total Expenses + 452.40 377.45 357.45 380.99 338.42
Cost of Materials Consumed 262.75 173.76 178.76 215.82 254.49
Employee Benefit Expense 62.93 52.92 54.76 38.60 30.81
Other Expenses 125.23 96.64 96.37 98.33 99.96
Operating Profit 53.46 5.26 36.06 42.62 95.23
OPM % 10.6% 1.4% 9.2% 10.1% 22%
Profit Before Exceptional 57.01 7.58 43.57 48.37 104.12
Exceptional Items 0.00 0.00 0.00 -3.59 0.00
Profit Before Tax + 57.01 7.58 43.57 44.78 104.12
Tax Expense 14.96 1.87 13.21 -0.71 8.25
Tax % 26.2% 24.6% 30.3% -1.6% 7.9%
Profit After Tax 42.05 5.71 30.35 45.49 95.87
EPS (Basic) 17.98 2.44 13.26 20.52 44.59

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022
ASSETS
Non-Current Assets + 654.18 571.00 520.81 442.75 222.42
Property, Plant & Equipment 604.15 525.55 426.54 195.77 159.30
Capital Work in Progress 23.35 21.54 72.93 230.74 51.49
Non-Current Investments 4.00 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 5.26 3.12 0.35 0.48 0.32
Current Assets + 349.51 265.25 297.91 313.56 435.89
Inventories 196.07 133.95 152.77 162.50 169.96
Trade Receivables 119.03 82.53 69.85 84.40 56.60
Cash and Cash Equivalents 5.76 11.37 35.30 27.37 63.02
Current Investments 0.00 0.00 10.05 0.00 0.00
LIABILITIES & EQUITY
Total Equity 781.76 738.82 737.08 514.79 473.09
Equity Share Capital 23.39 23.39 23.39 22.17 22.17
Other Equity 758.37 715.43 713.69 492.63 450.92
Non-Current Liabilities 8.80 1.40 1.97 5.38 13.78
Current Liabilities 213.14 96.03 79.66 236.13 171.43
Total Liabilities 221.94 97.43 81.64 241.51 185.21

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022
Cash from Operating Activities 31.49 24.67 98.04 27.78 20.38
Cash from Investing Activities -115.84 -65.25 -120.54 -101.14 -196.81
Cash from Financing Activities 78.93 16.57 30.52 37.80 234.96
Net Increase/Decrease in Cash -5.61 -23.93 7.94 -35.65 58.54